🔗 Permalink

Inventor profile of:

Michael S. Kinch

City:

Laytonsville, Maryland

Country:

United States

Published Applications:

Last publication date:

2024-03-28

Top Assignees for applications by Michael S. Kinch

The entities that hold a legal rights for patent applications filed by inventor Kinch Michael S.:

UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 8 Pittsburgh, PA United States
PURDUE RESEARCH FOUNDATION 7 West Lafayette, IN United States
MEDIMMUNE, INC. 7 Gaithersburg, MD United States
MEDIMMUNE, LLC 6 Gaithersburg, MD United States
Seattle Genetics, Inc. 2 Bothell, WA United States
Functional Genetics, Inc. 1 Gaithersburg, MD United States
Purdue Research Foundation 1 West Lafayette, India
Medlmmune, Inc 1 Gaithersburg, MD United States
University Of Pittsburgh—Of the Commonwealth System Of Higher 1 Pittsburgh, PA United States
University of Pittsburgh 1 Pittsburgh, PA United States
ELI LILLY AND COMPANY 1 Indianapolis, IN United States
Medimmune, Inc. 1 Gaitherburg, MD United States

Recent patent applications by Kinch Michael S.

Michael S. Kinch from Laytonsville, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-28

US20240101625A1

Chemistry; metallurgy

EPHA2 T-CELL EPITOPE AGONISTS AND USES THEREFORE

#2 | 2021-07-01

US20210198333A1

Chemistry; metallurgy

EphA2 T-cell epitope agonists and uses therefore

#3 | 2019-01-24

US20190023756A1

Chemistry; metallurgy

EPHA2 t-cell epitope agonists and uses therefore

#4 | 2017-01-05

US20170002050A1

Chemistry; metallurgy

EphA2 T-cell epitope agonists and uses therefore

#5 | 2014-09-18

US20140271671A1

Chemistry; metallurgy

RANDOM HOMOZYGOUS GENE PERTURBATION (RHGP) WITH THERMAL ASSYMETRIC INTERLACED (TAIL)-PCR

#6 | 2014-05-15

US20140134198A1

Chemistry; metallurgy

EphA2 T-cell epitope agonists and uses therefore

#7 | 2012-08-09

US20120201840A1

Chemistry; metallurgy

EphA2 T cell epitopes and uses therefor

#8 | 2012-05-17

US20120122112A1

Physics

ANTIBODIES AS A CANCER DIAGNOSTIC

#9 | 2012-05-17

US20120121582A1

Chemistry; metallurgy

Modulators Of EphA2 And Ephrina1 For The Treatment Of Fibrosis-Related Disease

#10 | 2011-11-17

US20110280892A1

Chemistry; metallurgy

TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES

#11 | 2011-06-23

US20110150898A1

Chemistry; metallurgy

EPHA2 as a therapeutic target for cancer

#12 | 2011-03-03

US20110053182A1

Physics

DIAGNOSIS OF PRE-CANCEROUS CONDITIONS USING PCDGF AGENTS

#13 | 2010-11-25

US20100298545A1

Chemistry; metallurgy

EphA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF

#14 | 2010-11-04

US20100278838A1

Chemistry; metallurgy

EPHA2 MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF

#15 | 2010-10-14

US20100260749A1

Chemistry; metallurgy

Modulators of EphA2 and Ephrin-A1 for the treatment of fibrosis-related disease

#16 | 2010-07-22

US20100183628A1

Chemistry; metallurgy

Methods of inhibiting HIV infectivity

#17 | 2010-07-01

US20100166657A1

Chemistry; metallurgy

USE OF EphA4 AND MODULATOR OF EphA4 FOR DIAGNOSIS, TREATMENT AND PREVENTION OF CANCER

#18 | 2010-06-10

US20100143345A1

Chemistry; metallurgy

EPHA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF

#19 | 2009-12-10

US20090304721A1

Chemistry; metallurgy

TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES

#20 | 2009-06-25

US20090162933A1

Chemistry; metallurgy

EPHA2 AND HYPERPROLIFERATIVE CELL DISORDERS

#21 | 2008-09-18

US20080226665A1

Chemistry; metallurgy

EphA2 T-cell epitopes and uses therefor

#22 | 2008-04-17

US20080089931A1

Human necessities

EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders

#23 | 2008-02-21

US20080044413A1

Chemistry; metallurgy

EphA2 BiTE molecules and uses thereof

#24 | 2007-07-19

US20070166314A1

Chemistry; metallurgy

EpA2 monoclonal antibodies and methods of use thereof

#25 | 2007-07-12

US20070161064A1

Physics

Antibodies as a cancer diagnostic

#26 | 2007-06-14

US20070134254A1

Chemistry; metallurgy

EphA2 agonistic monoclonal antibodies and methods of use thereof

#27 | 2007-04-19

US20070086943A1

Chemistry; metallurgy

EphA2 agonistic monoclonal antibodies and methods of use thereof

#28 | 2007-03-22

US20070065887A1

Physics

Diagnosis of pre-cancerous conditions using pcdgf agents

#29 | 2006-06-08

US20060122138A1

Chemistry; metallurgy

Modulators of EphA2 and EphrinA1 for the treatment of fibrosis-related disease

#30 | 2006-06-08

US20060121043A1

Chemistry; metallurgy

Use of modulators of EphA2 and EphrinA1 for the treatment and prevention of infections

#31 | 2006-06-08

US20060121042A1

Chemistry; metallurgy

Modulation of antibody specificity by tailoring the affinity to cognate antigens

#32 | 2006-04-27

US20060088541A1

Chemistry; metallurgy

EphA2 as a therapeutic target for cancer

#33 | 2006-01-26

US20060019899A1

Chemistry; metallurgy

EphA2 T-cell epitopes and uses therefor

#34 | 2005-12-22

US20050281783A1

Human necessities

Listeria-based EphA2 vaccines

#35 | 2005-08-09

US9640935

Treatment of metastatic disease

#36 | 2005-08-04

US20050169931A1

Chemistry; metallurgy

EphA2 as a therapeutic target for cancer

#37 | 2005-07-14

US20050153923A1

Chemistry; metallurgy

Targeted drug delivery using EphA2 or EphA4 binding moieties

#38 | 2005-07-14

US20050152899A1

Chemistry; metallurgy

EphA2 agonistic monoclonal antibodies and methods of use thereof

#39 | 2005-07-07

US20050147593A1

Human necessities

EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders

#40 | 2005-03-17

US20050059592A1

Chemistry; metallurgy

EphA2 and hyperproliferative cell disorders

#41 | 2005-03-03

US20050049176A1

Chemistry; metallurgy

EphA2, hypoproliferative cell disorders and epithelial and endothelial reconstitution

#42 | 2005-03-03

US20050048550A1

Chemistry; metallurgy

EphA2 T-cell epitope agonists and uses therefor

#43 | 2005-01-20

US20050013819A1

Chemistry; metallurgy

EphA4 Antibodies

InventorID:

761968 ⎘